Table 2 Prediction of gastrointestinal symptoms over chemotherapy using pre-chemotherapy alpha diversity

From: Baseline gut microbiome alpha diversity predicts chemotherapy-induced gastrointestinal symptoms in patients with breast cancer

  

During Chemotherapy

Post-Chemotherapy

Model

Outcome

Estimate

SE

p

Estimate

SE

p

Step 1

Diarrhea

−2.76

0.92

0.003

−1.30

0.91

0.156

 

Nausea/vomiting

−1.21

0.87

0.167

−1.83

0.86

0.033

Step 2

Diarrhea

−2.50

0.89

0.006

−1.01

0.89

0.258

 

Nausea/vomiting

−0.95

0.87

0.276

−1.59

0.87

0.066

  1. Step 1 models adjusted for baseline outcome level. Step 2 models additionally adjusted for baseline age, menopausal status, body mass index, and chemotherapy regimen. n = 54–55. SE standard error. Bold p values are significant at p < 0.05.
Back to article page